Endometrial ablation using a distensible multielectrode balloon: a long-term follow-up report

Abstract

Objective To present long term follow up data on patients treated at The Royal Surrey County Hospital, who took part in an evaluation study of the Vesta™ system. Study design A prospective follow-up study at 3.5–5 years following treatment. Subjects and methods Twenty-five patients were asked to complete a questionnaire detailing their medical history since the initial Vesta™ system procedure, together with a validated pictorial blood loss assessment chart. A life table analysis of the patients enrolled into the European study was also carried out at 2 years. Results Of the 25 patients, a TCRE had to be carried out as a second operation in two patients because of continuing menorrhagia, and one patient had a pictorial blood loss score of >150 but did not want further treatment at 5 years. Therefore, treatment with the Vesta™ system failed to relieve the original symptoms or avoid second surgery in 3/25 (12%) of the patients in the long term. Life table analysis of the patients enrolled into the European study has demonstrated a failure rate of 11% at 2 years. Conclusion Our long term results suggest that the efficacy of the Vesta™ System at 2 years persists at 3.5–5 years following treatment.